Loading...
Whole-genome approach implicates CD44 in cellular resistance to carboplatin
Carboplatin is a chemotherapeutic agent used in the management of many cancers, yet treatment is limited by resistance and toxicities. To achieve a better understanding of the genetic contribution to carboplatin resistance or toxicities, lymphoblastoid cell lines from 34 large Centre d'Etude du...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2683878/ https://ncbi.nlm.nih.gov/pubmed/19164090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-7364-3-2-128 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|